Buprenorphine in Acute Renal Colic Pain Management
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to determine whether sublingual Buprenorphine is as effective as Iv Morphine sulfate on pain control of the patients with acute renal colic in the emergency department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Mar 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 1, 2012
CompletedFirst Posted
Study publicly available on registry
March 7, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedDecember 10, 2012
December 1, 2012
1.1 years
March 1, 2012
December 6, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
change in pain score
change in pain severity based on Numerical Rating Score
20 and 40 minutes
Secondary Outcomes (1)
treatment side effects
40 minutes
Study Arms (2)
Buprenorphine
EXPERIMENTALRenal Colic Patients treated by 2 mg sublingual Buprenorphine.
Morphine
ACTIVE COMPARATORRenal Colic Patients treated by 0.1 mg/kg intravenous morphine.
Interventions
Eligibility Criteria
You may qualify if:
- clinical diagnosis of acute renal colic; positive urinalysis of hematuria; pain score more than 3 in Numerical Rating Score (NRS); patients sign the informed consent to enroll.
You may not qualify if:
- previous history of seizures; cardiovascular, hepatic, renal or metabolic diseases;
- febrile patients (T \> 38°C);
- hemodynamically unstable patients ( Systolic Blood Pressure \< 90 mmHg);
- pregnant patients;
- patients with abdominal tenderness as a sign of peritoneal inflammation;
- any clinical suspicion for diseases other than urolithiasis like abdominal aortic aneurysm or dissection;
- patients with a history of drug addiction or known allergy to opioids;
- patients who had used analgesics 6 hours before arriving.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
TUMS
Tehran, Tehran Province, 1417613151, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohammad Jalili, MD
TUMS
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2012
First Posted
March 7, 2012
Study Start
March 1, 2011
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
December 10, 2012
Record last verified: 2012-12